FDA Grants Orphan Drug Designation for the Treatment of Scleroderma
/PRNewswire/ -- BLR Bio, an emerging biotechnology company in Rosalind Franklin University's Helix 51 biomedical incubator, announced that the U.S. Food and...
Source: prnewswire.com